Vitiligo and Quality of Life

Aug 20, 2017 by in Dermatology Comments Off on Vitiligo and Quality of Life

© Springer India 2017Evangeline B. Handog and Maria Juliet Enriquez-Macarayo (eds.)Melasma and Vitiligo in Brown Skin10.1007/978-81-322-3664-1_30 30. Vitiligo and Quality of Life Marcia Ramos-e-Silva1  , Felipe Cupertino de Andrade1 and João Paulo Niemeyer-Corbellini1 (1) Sector of Dermatology and Post-Graduation Course, University Hospital…

read more

Phototherapy in Vitiligo

Aug 20, 2017 by in Dermatology Comments Off on Phototherapy in Vitiligo

Fig. 29.1 Phototherapy algorithm. BSA body surface area, CS corticosteroids, CI calcineurin inhibitors, NB-UVB narrowband ultraviolet B Table 29.1 Combinations in phototherapy Author (year) N Type of trial Therapy combined…

read more

Prevalent Skin Disorders in Brown Skin

Aug 20, 2017 by in Dermatology Comments Off on Prevalent Skin Disorders in Brown Skin

© Springer India 2017Evangeline B. Handog and Maria Juliet Enriquez-Macarayo (eds.)Melasma and Vitiligo in Brown Skin10.1007/978-81-322-3664-1_2 2. Prevalent Skin Disorders in Brown Skin Maria Juliet Enriquez-Macarayo1   and Evangeline B. Handog2   (1) Dermatology Department, Angeles University Foundation Medical Center, Angeles…

read more

Oral Medications in Vitiligo

Aug 20, 2017 by in Dermatology Comments Off on Oral Medications in Vitiligo

© Springer India 2017Evangeline B. Handog and Maria Juliet Enriquez-Macarayo (eds.)Melasma and Vitiligo in Brown Skin10.1007/978-81-322-3664-1_27 27. Oral Medications in Vitiligo Koushik Lahiri1   and Samujjala Deb2   (1) Apollo Gleneagles Hospitals, WIZDERM, Greenwood Nook, Coral Isle-14 RB, 369/2…

read more

Topical Medications in Vitiligo

Aug 20, 2017 by in Dermatology Comments Off on Topical Medications in Vitiligo

Drug Mechanism of action Level of evidence Corticosteroids Modulate the immune response by reducing the macrophages and T cells Reduce autoantibodies Inhibit complement-mediated melanocyte destruction IA Calcineurin inhibitors Reduce the…

read more

Comorbidities in Vitiligo

Aug 20, 2017 by in Dermatology Comments Off on Comorbidities in Vitiligo

1. Autoimmune disorders   1.1 Systemic diseases Hashimoto thyroiditis Myasthenia gravis Graves’ disease Sjögren’s syndrome Systemic lupus erythematosus (SLE) Inflammatory bowel disease (IBD) Rheumatoid arthritis  1.2 Dermatoses Alopecia areata  1.3 Autoimmune…

read more

Pathogenesis of Vitiligo

Aug 20, 2017 by in Dermatology Comments Off on Pathogenesis of Vitiligo

Fig. 20.1 Factors leading to melanocyte death 20.11 Conclusion Though the exact causation of vitiligo still eludes us, it is safe to assume that several different pathophysiologic mechanisms may be…

read more

Vitiligo: Definition, Incidence, Etiology

Aug 20, 2017 by in Dermatology Comments Off on Vitiligo: Definition, Incidence, Etiology

Chromosome Gene Protein Function Casual variant Other autoimmune disease associations 1p36.23 REREa Atrophin-like protein 1 Regulates apoptosis   1p13.2 PTPN22 a Lymphoid-specific protein tyrosine phosphatase nonreceptor type 22 Regulates T-cell receptor…

read more

Topical Agents in Melasma

Aug 20, 2017 by in Dermatology Comments Off on Topical Agents in Melasma

© Springer India 2017Evangeline B. Handog and Maria Juliet Enriquez-Macarayo (eds.)Melasma and Vitiligo in Brown Skin10.1007/978-81-322-3664-1_12 12. Topical Agents in Melasma Ma. Flordeliz Abad-Casintahan1   and Hester Gail Lim1   (1) Department of Dermatology, Jose R. Reyes Memorial Medical Center, Rizal…

read more

Quality of Life in Melasma

Aug 20, 2017 by in Dermatology Comments Off on Quality of Life in Melasma

Fig. 18.1 Facial melasma in an adult (a) female patient (b) male patient The quality of life measures used for the evaluation of melasma impact on everyday life are summarized….

read more
Get Clinical Tree app for offline access